Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

101.78M

Fund Score

iShares Genomics Immunology and Healthcare ETF Price, Quotes and Forecasts | ARCA:IDNA | Benzinga

Explore iShares Genomics Immunology and Healthcare ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IDNA.

Open	$19.53
High	$19.71
52 Wk High	$25.80
AUM	101.78M
Dividend	$0.26
Ex-Div Date	Dec 17, 2024
Volume	22.69K
Market Cap	$27.06B
Mgmt Fee	0.47%
P/E Ratio	21.05
Prev. Close	$19.59
Low	$19.16
52 Wk Low	$17.26
Shares Out	5.85M
Yield	1.36%
Div. Freq	S
Avg. Volume Daily	35.77K
Beta	1.05
Avg. Expense Ratio	0.47%
P/B Ratio	2.88

Recent News

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for rare tumor treatments and immediate revenue growth.

Lekha Gupta

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald Trump's executive order to withdraw from the global health body.

Kaustubh Bagalkote

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Chandrima Sanyal

FAQ

How do I buy iShares Genomics Immunology and Healthcare ETF (IDNA) stock?

You can purchase shares of iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) through any online brokerage.

View our list of the best stock brokerages

Who are iShares Genomics Immunology and Healthcare ETF (IDNA) competitors?

There are no as such competitors for iShares Genomics Immunology and Healthcare ETF.

What is the forecast, or price target, for iShares Genomics Immunology and Healthcare ETF (IDNA) stock?

There is no analysis for iShares Genomics Immunology and Healthcare ETF to provide a consensus price target.

What is the current price for iShares Genomics Immunology and Healthcare ETF (IDNA)?

The stock price for iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA) is $19.16 last updated May 9, 2025 at 8:00 PM EDT.

Does iShares Genomics Immunology and Healthcare ETF (IDNA) pay a dividend?

There are no upcoming dividends for iShares Genomics Immunology and Healthcare ETF.

When is iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) reporting earnings?

iShares Genomics Immunology and Healthcare ETF does not have any upcoming earnings scheduled.

Is iShares Genomics Immunology and Healthcare ETF (IDNA) going to split?

There is no upcoming split for iShares Genomics Immunology and Healthcare ETF.

Open	$19.53
High	$19.71
52 Wk High	$25.80
AUM	101.78M
Dividend	$0.26
Ex-Div Date	Dec 17, 2024
Volume	22.69K
Market Cap	$27.06B
Mgmt Fee	0.47%
P/E Ratio	21.05
Prev. Close	$19.59
Low	$19.16
52 Wk Low	$17.26
Shares Out	5.85M
Yield	1.36%
Div. Freq	S
Avg. Volume Daily	35.77K
Beta	1.05
Avg. Expense Ratio	0.47%
P/B Ratio	2.88

About iShares Trust

Sector

N/A

Industry

N/A

Got Questions? Ask

How is the earnings season affecting IDNA?

Show IDNA's technical analysis

What is IDNA's current market cap?

What is IDNA's free cash flow?

What is IDNA's gross margin?

ETF Details

Sector	Healthcare
Category	High Performer-High Growth
Investment Style	Mid Cap Growth
Fund Inception	Jun 11, 2019
Managers	Paul Whitehead Greg Savage Jennifer Hsui
Definition	An equity fund portfolio full of stocks with both strong financial performance and superior growth potential

Investment Policy

The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Top ETF Holdings

Symbol	Name	Share %
SM	Roche Holding A.G.	5.49%
GILD	Gilead Sciences Inc	4.62%
SRPT	Sarepta Therapeutics I...	4.53%
RVMD	Revolution Medicines I...	4.44%
INCY	Incyte Corp.	4.30%
REGN	Regeneron Pharmaceutic...	4.23%
EXEL	Exelixis Inc	5.05%
TK	Takeda Pharmaceutical ...	4.95%
PA	Sanofi SA	5.54%
HK	Beigene, Ltd.	6.57%
SWTX	Springworks Therapeuti...	4.73%
LN	GSK plc	5.40%
CO	Genmab A.S.	4.33%
MRK	Merck & Co. Inc.	4.26%

Comments

iShares Genomics Immunology and Healthcare ETF Stock Price, Quotes and Forecasts

Overview